Back
Akero Therapeutics Stock Price Chart

Something is Coming for America's Top Stock
Click here to learn its name and why.
Buy
65
AKRO
Akero Therapeutics
Last Price:
19.78
Seasonality Move:
2.55%
7 Day Trial
ALL ACCESS PASS
$
7

Tech insider: "Watch your mailbox"
Full story here.- The current trend is relatively stagnant and AKRO is experiencing slight buying pressure.
Akero Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.37 | Buy |
20-day SMA: | 16.06 | Buy |
50-day SMA: | 20.72 | Sell |
200-day SMA: | 39.22 | Sell |
8-day EMA: | 17.59 | Buy |
20-day EMA: | 16.92 | Buy |
50-day EMA: | 21.71 | Sell |
200-day EMA: | 34.15 | Sell |
Akero Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.3 | Sell |
Relative Strength Index (14 RSI): | 59.09 | Buy |
Chaikin Money Flow: | 330879 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.18 - 17.2) | Buy |
Bollinger Bands (100): | (17.72 - 49.78) | Sell |
Akero Therapeutics Technical Analysis
Nov 22 | Nov 24 | Nov 27 | Nov 28 | Nov 29 | Nov 30 | Dec 1 | Dec 4 | Dec 5 | Dec 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
22 | 24 | 27 | 28 | 29 | 30 | 01 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Akero Therapeutics Stock
Is Akero Therapeutics Stock a Buy?
- Akero Therapeutics share price is 19.05 while AKRO 8-day simple moving average is 17.37, which is a Buy signal.
- The stock price of AKRO is 19.05 while Akero Therapeutics 20-day SMA is 16.06, which makes it a Buy.
- Akero Therapeutics 50-day simple moving average is 20.72 while AKRO share price is 19.05, making it a Sell technically.
- AKRO stock price is 19.05 and Akero Therapeutics 200-day simple moving average is 39.22, creating a Sell signal.
AKRO Technical Analysis vs Fundamental Analysis
Buy
65
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy or a Sell?
-
Akero Therapeutics stock is rated a Buy
The current Akero Therapeutics [AKRO] share price is $19.05. The Score for AKRO is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
Akero Therapeutics Stock Info
Market Cap:
1.06B
Price in USD:
19.05
Share Volume:
999.72K
Akero Therapeutics 52-Week Range
52-Week High:
58.38
52-Week Low:
11.25
Buy
65
Akero Therapeutics (AKRO)
is a Buy
Akero Therapeutics Share Price Forecast
-
What is the Akero Therapeutics stock price today?
The Akero Therapeutics stock price is 19.05 USD today. -
Will AKRO stock go up or go down?
Akero Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Akero Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akero Therapeutics is not overvalued.
Is Akero Therapeutics Stock a Buy?
- Akero Therapeutics share price is 19.05 while AKRO 8-day exponential moving average is 17.59, which is a Buy signal.
- The stock price of AKRO is 19.05 while Akero Therapeutics 20-day EMA is 16.92, which makes it a Buy.
- Akero Therapeutics 50-day exponential moving average is 21.71 while AKRO share price is 19.05, making it a Sell technically.
- AKRO stock price is 19.05 and Akero Therapeutics 200-day simple moving average is 34.15, creating a Sell signal.
Fundamental Analysis of Akero Therapeutics
Is Akero Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and a decrease next year of $0.77 per share.
Technical Analysis of Akero Therapeutics
Should I short Akero Therapeutics stock?
- AKRO Moving Average Covergence Divergence (MACD) indicator is -0.3, suggesting Akero Therapeutics is a Sell
- Akero Therapeutics Relative Strength Index (RSI) is 59.09, which suggest Akero Therapeutics is overbought
- The Bollinger Bands (25) for Akero Therapeutics is (14.18 - 17.2), which suggest Akero Therapeutics is a Sell
- The Bollinger Bands (100) for Akero Therapeutics is (17.72 - 49.78), which suggest Akero Therapeutics is a Sell
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.